Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49


Interplay between coding and exonic splicing regulatory sequences.

Fontrodona N, Aubé F, Claude JB, Polvèche H, Lemaire S, Tranchevent LC, Modolo L, Mortreux F, Bourgeois CF, Auboeuf D.

Genome Res. 2019 May;29(5):711-722. doi: 10.1101/gr.241315.118. Epub 2019 Apr 8.


The RNA helicase DDX17 controls the transcriptional activity of REST and the expression of proneural microRNAs in neuronal differentiation.

Lambert MP, Terrone S, Giraud G, Benoit-Pilven C, Cluet D, Combaret V, Mortreux F, Auboeuf D, Bourgeois CF.

Nucleic Acids Res. 2018 Sep 6;46(15):7686-7700. doi: 10.1093/nar/gky545.


Identification of protein features encoded by alternative exons using Exon Ontology.

Tranchevent LC, Aubé F, Dulaurier L, Benoit-Pilven C, Rey A, Poret A, Chautard E, Mortada H, Desmet FO, Chakrama FZ, Moreno-Garcia MA, Goillot E, Janczarski S, Mortreux F, Bourgeois CF, Auboeuf D.

Genome Res. 2017 Jun;27(6):1087-1097. doi: 10.1101/gr.212696.116. Epub 2017 Apr 18.


TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.

Mohamed AM, Balsat M, Koering C, Maucort-Boulch D, Boissel N, Payen-Gay L, Cheok M, Mortada H, Auboeuf D, Pinatel C, El-Hamri M, Tigaud I, Hayette S, Dumontet C, Cros E, Flandrin-Gresta P, Nibourel O, Preudhomme C, Thomas X, Nicolini FE, Solly F, Guyotat D, Campos L, Michallet M, Ceraulo A, Mortreux F, Wattel E.

Leuk Res. 2017 May;56:21-28. doi: 10.1016/j.leukres.2017.01.012. Epub 2017 Jan 16.


An miRNA-DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia.

Solly F, Koering C, Mohamed AM, Maucort-Boulch D, Robert G, Auberger P, Flandrin-Gresta P, Adès L, Fenaux P, Kosmider O, Tavernier-Tardy E, Cornillon J, Guyotat D, Campos L, Mortreux F, Wattel E.

Clin Cancer Res. 2017 Jun 15;23(12):3025-3034. doi: 10.1158/1078-0432.CCR-16-2304. Epub 2016 Nov 23.


The multiple functions of RNA helicases as drivers and regulators of gene expression.

Bourgeois CF, Mortreux F, Auboeuf D.

Nat Rev Mol Cell Biol. 2016 Jul;17(7):426-38. doi: 10.1038/nrm.2016.50. Epub 2016 Jun 2. Review.


Adult T-Cell Leukemia/Lymphoma in a Caucasian Patient After Sexual Transmission of Human T-Cell Lymphotropic Virus Type 1.

Sibon D, Cassar O, Duga I, Brouzes C, Ghez D, Pasquier C, Sibon C, Desrames A, Mortreux F, Wattel E, Bazarbachi A, Gessain A, Hermine O.

Open Forum Infect Dis. 2015 Mar 6;2(2):ofv032. doi: 10.1093/ofid/ofv032. eCollection 2015 Apr.


HBx triggers either cellular senescence or cell proliferation depending on cellular phenotype.

Idrissi ME, Hachem H, Koering C, Merle P, Thénoz M, Mortreux F, Wattel E.

J Viral Hepat. 2016 Feb;23(2):130-8. doi: 10.1111/jvh.12450. Epub 2015 Aug 28.


Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).

Mohamed AM, Balsat M, Thenoz M, Koering C, Payen-Gay L, Cheok M, Mortada H, Auboeuf D, Pinatel C, El-Hamri M, Dumontet C, Cros E, Flandrin-Gresta P, Nibourel O, Preudhomme C, Michallet M, Thomas X, Nicolini F, Solly F, Guyotat D, Campos L, Wattel E, Mortreux F.

Oncotarget. 2016 Jan 19;7(3):2889-909. doi: 10.18632/oncotarget.3898.


HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemia.

Thénoz M, Vernin C, Mortada H, Karam M, Pinatel C, Gessain A, Webb TR, Auboeuf D, Wattel E, Mortreux F.

Retrovirology. 2014 Dec 18;11:119. doi: 10.1186/s12977-014-0119-3.


How mRNA is misspliced in acute myelogenous leukemia (AML)?

Mohamed AM, Thénoz M, Solly F, Balsat M, Mortreux F, Wattel E.

Oncotarget. 2014 Oct 30;5(20):9534-45. Review.


HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating OncomiRs.

Vernin C, Thenoz M, Pinatel C, Gessain A, Gout O, Delfau-Larue MH, Nazaret N, Legras-Lachuer C, Wattel E, Mortreux F.

Cancer Res. 2014 Nov 1;74(21):6082-93. doi: 10.1158/0008-5472.CAN-13-3564. Epub 2014 Sep 9.


Immunological alterations and associated diseases in mandrills (Mandrillus sphinx) naturally co-infected with SIV and STLV.

Souquière S, Makuwa M, Sallé B, Lepelletier Y, Mortreux F, Hermine O, Kazanji M.

Virology. 2014 Apr;454-455:184-96. doi: 10.1016/j.virol.2014.02.019. Epub 2014 Mar 7.


Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias.

Karam M, Thenoz M, Capraro V, Robin JP, Pinatel C, Lancon A, Galia P, Sibon D, Thomas X, Ducastelle-Lepretre S, Nicolini F, El-Hamri M, Chelghoun Y, Wattel E, Mortreux F.

Neoplasia. 2014 Jan;16(1):21-30.


Mosaicism of HTLV-1 5' LTR CpG methylation in the absence of malignancy.

Sibon D, Zane L, Idrissi ME, Delfau-Larue MH, Gessain A, Gout O, Mortreux F, Wattel E.

Virus Res. 2013 Dec 26;178(2):452-61. doi: 10.1016/j.virusres.2013.08.010. Epub 2013 Sep 12.


Cause-specific telomere factors deregulation in hepatocellular carcinoma.

El Idrissi M, Hervieu V, Merle P, Mortreux F, Wattel E.

J Exp Clin Cancer Res. 2013 Sep 11;32:64. doi: 10.1186/1756-9966-32-64.


HTLV-1-associated inflammatory myopathies: low proviral load and moderate inflammation in 13 patients from West Indies and West Africa.

Desdouits M, Cassar O, Maisonobe T, Desrames A, Aouba A, Hermine O, Mikol J, Polivka M, Penisson-Besnier I, Marcorelles P, Zagnoli F, Papo T, Lacour A, Amoura Z, Haroche J, Cherin P, Teixeira A, Benveniste O, Herson S, Morin AS, Mortreux F, Wattel E, Huerre M, Cumont MC, Martin-Latil S, Butler-Browne G, Gout O, Taylor G, Gessain A, Ozden S, Ceccaldi PE.

J Clin Virol. 2013 May;57(1):70-6. doi: 10.1016/j.jcv.2012.12.016. Epub 2013 Jan 30.


Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma.

Rosewick N, Momont M, Durkin K, Takeda H, Caiment F, Cleuter Y, Vernin C, Mortreux F, Wattel E, Burny A, Georges M, Van den Broeke A.

Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2306-11. doi: 10.1073/pnas.1213842110. Epub 2013 Jan 23.


Antiretroviral therapy promotes an inflammatory-like pattern of human T-cell lymphotropic virus type 1 (HTLV-1) replication in human immunodeficiency virus type 1/HTLV-1 co-infected individuals.

Pomier C, Rabaaoui S, Pouliquen JF, Couppié P, El Guedj M, Nacher M, Lacoste V, Wattel E, Kazanji M, Mortreux F.

J Gen Virol. 2013 Apr;94(Pt 4):753-7. doi: 10.1099/vir.0.048348-0. Epub 2012 Dec 12.


HTLV-1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells.

Zane L, Sibon D, Capraro V, Galia P, Karam M, Delfau-Larue MH, Gilson E, Gessain A, Gout O, Hermine O, Mortreux F, Wattel E.

Int J Cancer. 2012 Aug 15;131(4):821-33. doi: 10.1002/ijc.26270. Epub 2012 Apr 18.


Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias.

Capraro V, Zane L, Poncet D, Perol D, Galia P, Preudhomme C, Bonnefoy-Berard N, Gilson E, Thomas X, El-Hamri M, Chelghoun Y, Michallet M, Wattel E, Mortreux F, Sibon D.

Exp Hematol. 2011 Feb;39(2):195-202.e2. doi: 10.1016/j.exphem.2010.10.008. Epub 2010 Nov 4.


Clonal expansion of HTLV-1 positive CD8+ cells relies on cIAP-2 but not on c-FLIP expression.

Zane L, Sibon D, Legras C, Lachuer J, Wierinckx A, Mehlen P, Delfau-Larue MH, Gessain A, Gout O, Pinatel C, Lançon A, Mortreux F, Wattel E.

Virology. 2010 Nov 25;407(2):341-51. doi: 10.1016/j.virol.2010.07.023. Epub 2010 Sep 22.


[Quality proceedings in point-of-care testing: tetanus test example].

Descamps-Pouchelle IM, Mortreux F, Sergent-Roumier AS, Gressier B.

Ann Biol Clin (Paris). 2010 Jul-Aug;68(4):499-507. doi: 10.1684/abc.2010.0462. French.


Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors.

Afonso PV, Mekaouche M, Mortreux F, Toulza F, Moriceau A, Wattel E, Gessain A, Bangham CR, Dubreuil G, Plumelle Y, Hermine O, Estaquier J, Mahieux R.

Blood. 2010 Nov 11;116(19):3802-8. doi: 10.1182/blood-2010-02-270751. Epub 2010 Jun 29.


Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo.

Zane L, Sibon D, Jeannin L, Zandecki M, Delfau-Larue MH, Gessain A, Gout O, Pinatel C, Lançon A, Mortreux F, Wattel E.

Retrovirology. 2010 Mar 11;7:17. doi: 10.1186/1742-4690-7-17.


Inhibition of the hTERT promoter by the proto-oncogenic protein TAL1.

Terme JM, Mocquet V, Kuhlmann AS, Zane L, Mortreux F, Wattel E, Duc Dodon M, Jalinot P.

Leukemia. 2009 Nov;23(11):2081-9. doi: 10.1038/leu.2009.131. Epub 2009 Jul 9.


T-cell tropism of simian T-cell leukaemia virus type 1 and cytokine profiles in relation to proviral load and immunological changes during chronic infection of naturally infected mandrills (Mandrillus sphinx).

Souquière S, Mouinga-Ondeme A, Makuwa M, Beggio P, Radaelli A, De Giuli Morghen C, Mortreux F, Kazanji M.

J Med Primatol. 2009 Aug;38(4):279-89. doi: 10.1111/j.1600-0684.2009.00356.x. Epub 2009 Apr 23.


A dose-effect relationship for deltaretrovirus-dependent leukemogenesis in sheep.

Pomier C, Alcaraz MT, Debacq C, Lançon A, Kerkhofs P, Willems L, Wattel E, Mortreux F.

Retrovirology. 2009 Apr 3;6:30. doi: 10.1186/1742-4690-6-30.


Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype.

Zane L, Sibon D, Mortreux F, Wattel E.

Front Biosci (Landmark Ed). 2009 Jan 1;14:3935-41. Review.


Early and transient reverse transcription during primary deltaretroviral infection of sheep.

Pomier C, Alcaraz MT, Debacq C, Lançon A, Kerkhofs P, Willems L, Wattel E, Mortreux F.

Retrovirology. 2008 Feb 1;5:16. doi: 10.1186/1742-4690-5-16.


Immunological changes and cytokine gene expression during primary infection with human T-cell leukaemia virus type 1 in squirrel monkeys (Saimiri sciureus).

Heraud JM, Merien F, Mortreux F, Mahieux R, Kazanji M.

Virology. 2007 May 10;361(2):402-11. Epub 2007 Jan 16.


Cell dynamics and immune response to BLV infection: a unifying model.

Florins A, Gillet N, Asquith B, Boxus M, Burteau C, Twizere JC, Urbain P, Vandermeers F, Debacq C, Sanchez-Alcaraz MT, Schwartz-Cornil I, Kerkhofs P, Jean G, Théwis A, Hay J, Mortreux F, Wattel E, Reichert M, Burny A, Kettmann R, Bangham C, Willems L.

Front Biosci. 2007 Jan 1;12:1520-31. Review.


HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.

Sibon D, Gabet AS, Zandecki M, Pinatel C, Thête J, Delfau-Larue MH, Rabaaoui S, Gessain A, Gout O, Jacobson S, Mortreux F, Wattel E.

J Clin Invest. 2006 Apr;116(4):974-83.


The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus).

Heraud JM, Mortreux F, Merien F, Contamin H, Mahieux R, Pouliquen JF, Wattel E, Gessain A, de Thé H, Bazarbachi A, Hermine O, Kazanji M.

Antiviral Res. 2006 Jul;70(3):132-9. Epub 2006 Feb 28.


Endemic versus epidemic viral spreads display distinct patterns of HTLV-2b replication.

Gabet AS, Moulés V, Sibon D, Nass CC, Mortreux F, Mauclère P, Gessain A, Murphy EL, Wattel E.

Virology. 2006 Feb 5;345(1):13-21. Epub 2005 Oct 26.


Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1.

Debacq C, Héraud JM, Asquith B, Bangham C, Merien F, Moules V, Mortreux F, Wattel E, Burny A, Kettmann R, Kazanji M, Willems L.

Oncogene. 2005 Nov 17;24(51):7514-23.


HPRT mutations, TCR gene rearrangements, and HTLV-1 integration sites define in vivo T-cell clonal lineages.

Allegretta M, Ardell SK, Sullivan LM, Jacobson S, Mortreux F, Wattel E, Albertini RJ.

Environ Mol Mutagen. 2005 Mar-Apr;45(2-3):326-37.


Fate of premalignant clones during the asymptomatic phase preceding lymphoid malignancy.

Moulés V, Pomier C, Sibon D, Gabet AS, Reichert M, Kerkhofs P, Willems L, Mortreux F, Wattel E.

Cancer Res. 2005 Feb 15;65(4):1234-43.


Reduced proviral loads during primo-infection of sheep by Bovine Leukemia virus attenuated mutants.

Debacq C, Sanchez Alcaraz MT, Mortreux F, Kerkhofs P, Kettmann R, Willems L.

Retrovirology. 2004 Oct 5;1:31.


Inactivation of hTERT transcription by Tax.

Gabet AS, Mortreux F, Charneau P, Riou P, Duc-Dodon M, Wu Y, Jeang KT, Wattel E.

Oncogene. 2003 Jun 12;22(24):3734-41.


Naturally occurring substitutions of the human T-cell leukemia virus type 1 3' LTR influence strand-transfer reaction.

Leclercq I, Mortreux F, Rabaaoui S, Jonsson CB, Wattel E.

J Virol Methods. 2003 May;109(2):105-17.


Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo.

Mortreux F, Gabet AS, Wattel E.

Leukemia. 2003 Jan;17(1):26-38. Review.


Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo.

Mortreux F, Leclercq I, Gabet AS, Leroy A, Westhof E, Gessain A, Wain-Hobson S, Wattel E.

J Natl Cancer Inst. 2001 Mar 7;93(5):367-77.


Basis of HTLV type 1 target site selection.

Leclercq I, Mortreux F, Gabet AS, Jonsson CB, Wattel E.

AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1653-9.


High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis.

Gabet AS, Mortreux F, Talarmin A, Plumelle Y, Leclercq I, Leroy A, Gessain A, Clity E, Joubert M, Wattel E.

Oncogene. 2000 Oct 12;19(43):4954-60.


Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo.

Leclercq I, Mortreux F, Cavrois M, Leroy A, Gessain A, Wain-Hobson S, Wattel E.

J Virol. 2000 Mar;74(5):2305-12.


Semiquantitative analysis of residual disease in patients treated for adult T-cell leukaemia/lymphoma (ATLL).

Leclercq I, Mortreux F, Morschhauser F, Duthilleul P, Desgranges C, Gessain A, Cavrois M, Vernant JP, Hermine O, Wattel E.

Br J Haematol. 1999 Jun;105(3):743-51.


Oligoclonal proliferation of human T-cell leukaemia virus type 1 bearing T cells in adult T-cell leukaemia/lymphoma without deletion of the 3' provirus integration sites.

Leclercq I, Cavrois M, Mortreux F, Hermine O, Gessain A, Morschhauser F, Wattel E.

Br J Haematol. 1998 Jun;101(3):500-6.


Supplemental Content

Loading ...
Support Center